Anavex Life Sciences Corp. (AVXL) NASDAQ

11.17

-0.19(-1.67%)

Updated at July 30 04:00PM

Currency In USD

Valuation

Market Cap474.1M
Enterprise Value341.91M
P/E Ratio-26.44
PEG Ratio-0.26
Price/Sales Ratio0
Price/Book Ratio9.53
Enterprise/Revenue0
Enterprise/EBITDA-34.55

Fiscal Year

Fiscal YearSeptember 30, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.31
Return On Equity-0.31

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-45.29M
Net Income-43M
Diluted EPS-0.52

Balance Sheet

Total Cash115.77M
Total Cash/Share1.36
Total Debt0
Total Debt/Equity0
Current Ratio14.79
Book Value Per Share1.17

Price History

52-Week Change64.26
52-Week High14.44
52-Week Low4.93
Moving Average 50 Days9.5
Moving Average 200 Days8.92

Statistics

Average Volume1.02M
Shares Outstanding85.42M
% Held by Institutions36.87

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:4
Last Split DateOctober 07, 2015